September 2016 - Volume 36 - Issue 3
pp: 231-352,e13-e15



Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement?

Felgueiras, Helena; Parra, Joana; Cruz, Simão; More

Journal of Neuro-Ophthalmology. 36(3):275-279, September 2016.

Idiopathic Intracranial Hypertension—A Comparison of Clinical Characteristics Between 4 Medical Centers in Different Geographic Regions of the World

Rosenblatt, Amir; Klein, Ainat; Roemer, Ségolène; More

Journal of Neuro-Ophthalmology. 36(3):280-284, September 2016.







PDF Only







Creator: Jason Roberts
Duration: 6:09
Journal of Neuro-Ophthalmology September 2016, Volume 36, Issue 3;
In this podcast, Dr Neil Miller,one of the authors of the editorial entitled “A Nonarteritic Anterior Ischemic Optic Neuropathy Clinical Trial: An Industry and NORDIC Collaboration” talks about what is the leading cause of sudden optic nerve–related vision loss in individuals over 50 years old (caused by inadequate blood supply to the optic nerve head). Dr Miller discusses QRK207. QRK207 will be the first trial to use a potential neuroprotective therapy delivered early to reduce permanent injury and lessen the vision loss from acute NAION.
1 2 3 4 5